loadpatents
name:-0.013478994369507
name:-0.0054700374603271
name:-0.0005040168762207
Khan; Mubeen Ahmed Patent Filings

Khan; Mubeen Ahmed

Patent Applications and Registrations

Patent applications and USPTO patent grants for Khan; Mubeen Ahmed.The latest application filed is for "process for the preparation of lasofoxifene tartrate".

Company Profile
0.8.13
  • Khan; Mubeen Ahmed - Navi Mumbai IN
  • Khan; Mubeen Ahmed - Mumbai IN
  • Khan; Mubeen Ahmed - Maharastra IN
  • Khan; Mubeen Ahmed - Navimumbai Maharastra india IN
  • Khan; Mubeen Ahmed - Navi Mumbai Maharashtra IN
  • Khan; Mubeen Ahmed - Mumbia IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Process for the preparation of lasofoxifene tartrate
Grant 8,937,188 - Khan , et al. January 20, 2
2015-01-20
Fosaprepitant dimeglumine intermediate, neutral fosaprepitant, and amorphous fosaprepitant dimeglumine and processes for their preparations
Grant 8,623,844 - Bhatt , et al. January 7, 2
2014-01-07
Amorphous bupropion hydrobromide and preparation thereof
Grant 8,450,376 - Sanganabhatla , et al. May 28, 2
2013-05-28
Process for the preparation of R-sitagliptin and its pharmaceutically acceptable salts thereof
Grant 8,334,385 - Arjunan , et al. December 18, 2
2012-12-18
Process For The Preparation Of Lasofoxifene Tartrate
App 20120045648 - Khan; Mubeen Ahmed ;   et al.
2012-02-23
Processes for the Preparation of Indiplon and Intermediates Thereof
App 20120028045 - Koilpillai; Joseph Prabahar ;   et al.
2012-02-02
Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
Grant 8,097,729 - Sawant , et al. January 17, 2
2012-01-17
Process For The Preparation Of Voriconazole
App 20110312977 - D'Souza; Francis Paul ;   et al.
2011-12-22
Process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof
App 20110281928 - Khan; Mubeen Ahmed ;   et al.
2011-11-17
Fosaprepitant Dimeglumine Intermediate, Neutral Fosaprepitant, And Amorphous Fosaprepitant Dimeglumine And Processes For Their Preparations
App 20110130366 - Bhatt; Navin Ganesh ;   et al.
2011-06-02
Amorphous Bupropion Hydrobromide And Preparation Thereof
App 20110105619 - Sanganabhatla; Shankar ;   et al.
2011-05-05
Process For The Preparation Of Paliperidone Intermediates
App 20110087024 - Prabahar; Koilpillai Joseph ;   et al.
2011-04-14
Amorphous Bazedoxifene Acetate And Preparation Thereof
App 20100310870 - Sanganabhatla; Shankar ;   et al.
2010-12-09
Solid Milnacipran And Process For The Preparation Of The Same
App 20100274050 - KOILPILLAI; Joseph Prabahar ;   et al.
2010-10-28
Process For The Preparation Of Esomeprazole Magnesium Dihydrate
App 20100267959 - KOILPILLAI; Joseph Prabahar ;   et al.
2010-10-21
Processes For The Preparation Of Bosentan And Its Intermediates Thereof
App 20100256371 - Yadav; Roop Singh ;   et al.
2010-10-07
Amorphous Varenicline Tartrate And Process For The Preparation Thereof
App 20090318460 - Khan; Mubeen Ahmed
2009-12-24
Polymorphic Form of Lercanidipine Hydrochloride and Process for the Preparation Thereof
App 20090221833 - Sawant; Mangesh Shivram ;   et al.
2009-09-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed